727 Resistance to enzalutamide and abiraterone drives tumor phenotypic plasticity and resistance to immune-mediated cytotoxicity

• Jeffrey Schlom,
• Claudia Palena,
• Kristen Fousek,
• Lucas Horn,
• Haiyan Qin,
• Madeline Dahut

Affiliations

Jeffrey Schlom

Laboratory of Tumor Immunology and Biology, National Cancer Institute, Bethesda, Maryland, USA

Claudia Palena

Laboratory of Tumor Immunology and Biology, National Cancer Institute, Bethesda, Maryland, USA

Kristen Fousek

Aff1 grid.39382.33000000012160926XBaylor College of Medicine Houston TX USA

Lucas Horn

1National Cancer Institute, Bethesda, MD, USA

Haiyan Qin

Department of Health Management, Shenzhen People`s Hospital, Second Clinical Medical College of Jinan University, First affiliated Hospital of South University of Science and Technology, Shenzhen, China

Madeline Dahut

NIH, Bethesda, MD, United States